| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-01-29 14:16 Tx date 2026-01-28 |
$NTLX
NeuroThera Labs Inc. |
Zuloff-Shani, Adi
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+600,000 vol |
600,000 | |
| Filed 2026-01-29 14:15 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
Zuloff-Shani, Adi
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-11 19:55 Tx date 2026-01-08 |
$NTLX
NeuroThera Labs Inc. |
Adler, Oz
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+600,000 vol |
600,000 | |
| Filed 2026-01-11 19:55 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
Adler, Oz
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-11 19:46 Tx date 2026-01-08 |
$NTLX
NeuroThera Labs Inc. |
Shrem, Itschak
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+400,000 vol |
400,000 | |
| Filed 2026-01-11 19:45 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
Shrem, Itschak
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-11 19:45 Tx date 2026-01-08 |
$NTLX
NeuroThera Labs Inc. |
David, Ohad
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2026-01-11 19:44 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
David, Ohad
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-11 19:43 Tx date 2026-01-08 |
$NTLX
NeuroThera Labs Inc. |
Dayan, Alon
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2026-01-11 19:42 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
Dayan, Alon
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-11 19:41 Tx date 2026-01-08 |
$NTLX
NeuroThera Labs Inc. |
VIDER, LIOR
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+150,000 vol |
150,000 | |
| Filed 2026-01-11 19:40 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
VIDER, LIOR
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-01-11 19:38 Tx date 2026-01-08 |
$NTLX
NeuroThera Labs Inc. |
Kabazo, Gabi
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+600,000 vol |
600,000 | |
| Filed 2026-01-11 19:36 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
Kabazo, Gabi
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-02 07:30 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
SciSparc Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
contingent rights
00 - Opening Balance-Initial SEDI Report
|
48,000,000 | ||
| Filed 2025-11-02 07:29 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
SciSparc Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
4,000,000 | ||
| Filed 2025-10-30 22:07 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
D'Silva, Jason Dominic
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$16,665
+166,650 vol $0.10 each |
1,066,650 | |
| Filed 2025-10-30 22:06 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
D'Silva, Jason Dominic
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options Incentive stock options
51 - Exercise of options
|
$-16,665
-166,650 vol $0.10 each |
0 | |
| Filed 2025-10-24 14:15 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
SciSparc Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
63,300,000 | ||
| Filed 2025-10-24 13:55 Tx date 2025-10-22 |
$NTLX
NeuroThera Labs Inc. |
Shrem, Itschak
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
600,000 |